Short- versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis (Q46604492)

23 December 2017

meta-analysis

0 references

title

Short- versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis (English)

1 reference

23 December 2017

1 reference

1 reference

Dimitrios K. Matthaiou

3

1 reference

23 December 2017

Matthew E. Falagas

1

object named as

Matthew E Falagas

1 reference

23 December 2017

author name string

Sofia G Avgeri

2

1 reference

23 December 2017

George Dimopoulos

4

1 reference

23 December 2017

Ilias I Siempos

5

1 reference

23 December 2017

language of work or name

English

0 references

publication date

8 May 2008

1 reference

23 December 2017

Journal of Antimicrobial Chemotherapy

published in

1 reference

23 December 2017

volume

62

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

442-450

1 reference

23 December 2017

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

1 reference

Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

A review of guidelines for antibacterial use in acute exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

Guidelines for the management of adult lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

Canadian guidelines for the management of acute exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

Comparison of first-line with second-line antibiotics for acute exacerbations of chronic bronchitis: a metaanalysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

Randomized, double-blind study comparing 5- and 7-day regimens of oral levofloxacin in patients with acute exacerbation of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

Pharmacokinetics and tolerability of extended-release clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

Actualización de las recomendaciones ALAT sobre la exacerbación infecciosa de la EPOC

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKN201

21 January 2018

Identifiers

DOI

10.1093/JAC/DKN201

1 reference

23 December 2017

PubMed ID

18467303

1 reference

23 December 2017